Breaking News
Get 45% Off 0
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks

Buy CrowdStrike As CRWD Stock Soars Amid Coronavirus Work Remote Push

By Zacks Investment ResearchStock MarketsMar 24, 2020 08:04AM ET
www.investing.com/analysis/buy-crowdstrike-as-crwd-stock-soars-amid-coronavirus-work-remote-push-200518387
Buy CrowdStrike As CRWD Stock Soars Amid Coronavirus Work Remote Push
By Zacks Investment Research   |  Mar 24, 2020 08:04AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
US500
+0.01%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DJI
-0.43%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AAPL
-2.70%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AMZN
+0.73%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
NFLX
+1.31%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ZM
-0.09%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

CrowdStrike (NASDAQ:CRWD) shares have soared over 50% since last Monday and it topped our Q4 fiscal 2020 earnings and revenue estimates on March 19. The cybersecurity firm also provided upbeat guidance amid the ongoing coronavirus economic downturn that has forced many to work remotely, if they can.

CrowdStrike’s Elevator Pitch

CrowdStrike was founded in 2011 and went public in June 2019. The firm focuses on cloud-delivered endpoint protection “built to stop breaches.” CRWD aims to protect workloads “across on-premise, virtualized, and cloud-based environments running on a variety of endpoints such as laptops, desktops, servers, virtual machines, and Internet of Things, or IoT, devices.”

Recent Financial Result Highlights

Last week, the cybersecurity company reported a much smaller-than-expected adjusted Q4 loss (-$0.02 vs. -$0.08), which also marked a huge improvement against Q4 FY19’s -$0.60 a share. CrowdStrike also saw its total fiscal 2020 revenue skyrocket 93%, with subscription sales up 99%.

The firm’s free cash flow came in at $12.5 million, against 2019’s negative $65.6 million. Plus, CrowdStrike has attracted larger clients to its SaaS subscription-based model.

The company added 870 net new subscription customers in Q4, to end the fiscal 2020 with roughly 5,400 customers. This marked a 116% expansion from a year ago and CrowdStrike noted that its “subscription customers that have adopted five or more cloud modules increased to 33%.”

CEO George Kurtz noted on CrowdStrike’s earnings call with analysts that it was landing more large customers that start with “ARR over $1 million.” Kurtz also detailed why the firm feels that it is well position both long-term and for the coronavirus selloff. “Cybersecurity is mission critical to both the public and private sector,” the chief executive told analysts last week.

“Endpoint or workload security is also essential to protecting a remote workforce. While the impact to the macroeconomy from the coronavirus is unfolding in real time, we know it is forcing companies to conduct business differently and rapidly shift to a remote workforce. With our cloud native platform, our lightweight agent that is easily deployed at scale and our frictionless go-to-market engine, CrowdStrike is uniquely positioned to meet their cybersecurity needs."

Other Fundamentals

As we said at the top, CRWD shares have soared roughly 56% over the last week, from $33 on March 16 to close regular trading Monday at $51.45 a share. This uptick came as the Dow, the S&P 500, and the Nasdaq all continued their historically quick selloffs, as Apple (NASDAQ:AAPL) and other giants fall.

Despite the recent surge, CrowdStrike stock still rests 50% below its 52-week highs of just over $100 per share that it hit in August 2019.

CrowdStrike’s longer-term earnings revision picture has turned more positive since it posted its results last week. This positivity helps CRWD boast a Zacks Rank #1 (Strong Buy) at the moment. The stock also holds a “B” grade for Growth in our Style Scores system.

Investors should also be happy to know that the firm provided conservative guidance to help account for the coronavirus. Yet, it still came in above Wall Street estimate, and CFO Burt Podbere said that CrowdStrike “derisked” its guidance and that it “pipeline is at record levels.”

Our Zacks estimates call for the company’s fiscal 2021 revenue to surge nearly 40% to reach $667.79 million. Peeking further ahead, CrowdStrike’s 2022 sales are projected to climb another 30% higher to $862.86 million.

At the bottom end of the income statement, CRWD’s adjusted fiscal year loss is expected to be cut in half from -$0.42 to -$0.21 a share. Then it looks set to race near adjusted profitability in FY22, with the firm expected to post an adjusted loss of just -$0.02 a share.

Bottom Line

The company also looks somewhat immune to the coronavirus selloff because as firms big and small start to work remotely, their cybersecurity concerns won’t go away—in fact, they will likely grow. CrowdStrike also clearly looks poised to grow in the long run as part of the growing cybersecurity industry.

And CRWD might be worth considering as part of a larger group of stocks that could benefit from the stay-at-home world we are currently living in. This list includes Zoom Video Communications (NASDAQ:ZM) , Netflix (NASDAQ:NFLX) , Amazon (NASDAQ:AMZN) , and others.

With that said, the market looks set to remain volatile, so even those high on CRWD should practice caution and not take too large of a position.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Amazon.com, Inc. (AMZN): Free Stock Analysis Report

Apple Inc. (AAPL): Free Stock Analysis Report

Netflix, Inc. (NFLX): Free Stock Analysis Report

Zoom Video Communications, Inc. (ZM): Free Stock Analysis Report

CrowdStrike Holdings Inc. (CRWD): Free Stock Analysis Report

Original post

Zacks Investment Research

Buy CrowdStrike As CRWD Stock Soars Amid Coronavirus Work Remote Push
 

Related Articles

Buy CrowdStrike As CRWD Stock Soars Amid Coronavirus Work Remote Push

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email